GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimian Group AB (FRA:0V0) » Definitions » Institutional Ownership

Vimian Group AB (FRA:0V0) Institutional Ownership : 21.43% (As of Apr. 29, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Vimian Group AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Vimian Group AB's institutional ownership is 21.43%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Vimian Group AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Vimian Group AB's Float Percentage Of Total Shares Outstanding is 0.00%.


Vimian Group AB Institutional Ownership Historical Data

The historical data trend for Vimian Group AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimian Group AB Institutional Ownership Chart

Vimian Group AB Historical Data

The historical data trend for Vimian Group AB can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 15.45 15.22 15.13 17.40 18.14 17.83 20.60 21.08 21.16 21.43

Vimian Group AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Vimian Group AB Business Description

Traded in Other Exchanges
Address
Riddargatan 19, Stockholm, SWE, SE-11457
Vimian Group AB specializes in the areas of animal health such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription and non-prescription treatments for preventive care, and treatment of chronic conditions for companion animals, with a strong position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.

Vimian Group AB Headlines

No Headlines